Rockefeller Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.82M Sell
70,560
-13,803
-16% -$1.53M 0.02% 683
2025
Q1
$9.45M Buy
84,363
+7,916
+10% +$887K 0.02% 583
2024
Q4
$7.05M Buy
76,447
+1,348
+2% +$124K 0.02% 633
2024
Q3
$6.29M Sell
75,099
-1,402
-2% -$117K 0.02% 648
2024
Q2
$5.25M Sell
76,501
-21,165
-22% -$1.45M 0.01% 676
2024
Q1
$7.15M Buy
97,666
+1,589
+2% +$116K 0.02% 591
2023
Q4
$7.78M Sell
96,077
-16,763
-15% -$1.36M 0.03% 531
2023
Q3
$8.46M Buy
112,840
+12,871
+13% +$965K 0.03% 466
2023
Q2
$7.7M Buy
99,969
+1,221
+1% +$94.1K 0.03% 506
2023
Q1
$8.19M Sell
98,748
-28,489
-22% -$2.36M 0.04% 463
2022
Q4
$10.9M Sell
127,237
-70,345
-36% -$6.04M 0.05% 341
2022
Q3
$12.2M Buy
197,582
+40,229
+26% +$2.48M 0.06% 306
2022
Q2
$9.73M Buy
157,353
+6,063
+4% +$375K 0.05% 354
2022
Q1
$8.99M Buy
151,290
+8,587
+6% +$510K 0.04% 394
2021
Q4
$10.4M Buy
142,703
+4,480
+3% +$325K 0.05% 344
2021
Q3
$9.65M Buy
138,223
+28,235
+26% +$1.97M 0.05% 322
2021
Q2
$7.57M Buy
109,988
+66,789
+155% +$4.6M 0.04% 348
2021
Q1
$2.79M Buy
43,199
+6,253
+17% +$404K 0.02% 503
2020
Q4
$2.15M Buy
36,946
+1,123
+3% +$65.4K 0.02% 502
2020
Q3
$2.26M Buy
35,823
+10,854
+43% +$686K 0.02% 391
2020
Q2
$1.92M Buy
24,969
+1,183
+5% +$91K 0.02% 401
2020
Q1
$1.78M Buy
23,786
+1,296
+6% +$96.9K 0.02% 357
2019
Q4
$1.46M Buy
22,490
+10,915
+94% +$709K 0.02% 391
2019
Q3
$733K Sell
11,575
-22,373
-66% -$1.42M 0.01% 438
2019
Q2
$2.29M Sell
33,948
-1,894
-5% -$128K 0.03% 240
2019
Q1
$2.33M Sell
35,842
-16,123
-31% -$1.05M 0.03% 236
2018
Q4
$3.25M Buy
51,965
+42,385
+442% +$2.65M 0.06% 152
2018
Q3
$740K Sell
9,580
-10,381
-52% -$802K 0.01% 237
2018
Q2
$1.41M Buy
19,961
+2,147
+12% +$152K 0.02% 187
2018
Q1
$1.34M Buy
+17,814
New +$1.34M 0.02% 195